Clinical Trials on Schizoaffective Disorders in New Zealand

Total 16195 results

Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

Schizophrenia, Schizoaffective Disorder

United States
Hoffmann-La Roche

Terminated

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Schizophrenia, Schizoaffective Disorder

United States, Spain, Japan, Ukraine
Solvay Pharmaceuticals
Wyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/S

Completed

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Schizophrenia and Schizoaffective Disorder

Hungary, United States, Argentina, Canada, Czech Republic, Estonia, France, Latvia, Lithuania
Weill Medical College of Cornell University
Stanley Medical Research Institute

Completed

Efficacy of Pregnenolone in Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Columbia University
National Institute of Mental Health (NIMH)

Recruiting

Effectiveness of Motivation Skills Training (MST) (MST)

Schizophrenia | Schizoaffective Disorder

United States
VA Connecticut Healthcare System
Eli Lilly and Company; Clinical Trials Network of Columbia U, Cornell U, and...

Withdrawn

Zyprexa and Task Engagement in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
University of Otago

Enrolling by invitation

Psilocybin-assisted Interpersonal Therapy for Depression

Depressive Disorder, Treatment-Resistant

New Zealand
Rutgers, The State University of New Jersey
National Institute on Drug Abuse (NIDA)

Completed

Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness

Schizophrenia | Schizoaffective Disorder

United States
Columbia University
National Institute of Mental Health (NIMH)

Completed

Motivation Skills Training for Schizophrenia (MST)

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH); National Alliance for Research...

Terminated

Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)

Schizophrenia | Schizoaffective Disorder

United States
University of Otago
oVRcome

Completed

oVRcome - Self Guided Virtual Reality for Social Anxiety Disorder

Social Anxiety

New Zealand
Yale University

Terminated

A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia (CRC)

Schizophrenia | Schizoaffective Disorder

United States
Nathan Kline Institute for Psychiatric Research
Columbia University

Unknown

N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Nathan Kline Institute for Psychiatric Research
Stanley Medical Research Institute

Completed

Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Research Foundation for Mental Hygiene, Inc.
National Alliance for Research on Schizophrenia and Depression; New York State...

Terminated

A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis

Schizophrenia | Schizoaffective Disorder | Psychosis

United States
Bronx Psychiatric Center

Completed

Study of Vitamin D in the Severely Mentally Ill

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
Nathan Kline Institute for Psychiatric Research

Completed

Remediation of Auditory Recognition in Schizophrenia With tDCS

Schizophrenia | Schizoaffective Disorder

United States
Icahn School of Medicine at Mount Sinai
Brain & Behavior Research Foundation

Completed

Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
Stanley Medical Research Institute

Completed

Kuvan in People With Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute

Completed

Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Personalized and Scalable Cognitive Remediation Approaches

Schizophrenia | Schizoaffective Disorder

United States
Bronx Psychiatric Center
Pfizer; Buffalo Psychiatric Center; Rochester Psychiatric Center

Completed

Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics

Schizophrenia | Schizoaffective Disorder

United States
Center for Social Innovation, Massachusetts
National Institute of Mental Health (NIMH); New York State Psychiatric Institute and other collaborators

Completed

OnTrack>An Online Role-Playing Game for Young People With First Episode Psychosis

Schizophrenia | Schizoaffective Disorder | Psychosis

United States
State University of New York - Upstate Medical...
Cephalon

Completed

Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) (vivitrol)

Alcohol Dependence | Schizophrenia | Schizoaffective Disorders | Bipolar Disorders

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

M1 Schizophrenia PET Study

Healthy | Schizophrenia | Schizoaffective Disorder

United States
Dartmouth-Hitchcock Medical Center

Completed

Development of a Mobile System for Self-management of Schizophrenia (SOS)

Schizophrenia | Schizoaffective Disorder

United States
VA Connecticut Healthcare System
Brain & Behavior Research Foundation

Unknown

Perceptual Deficits in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Nathan Kline Institute for Psychiatric Research

Completed

Biomarkers in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Center for Social Innovation, Massachusetts
Research Foundation for Mental Hygiene, Inc.

Completed

OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant

Schizophrenia | Schizoaffective Disorder | Psychosis

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Clinical Trial of AVL-3288 in Schizophrenia Patients

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Improving Accessibility and Personalization of CR for Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Manhattan Psychiatric Center
Azur Pharma, Inc

Completed

Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Juul Labs, Inc.

Completed

Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, Cigarettes

New Zealand
Nathan Kline Institute for Psychiatric Research
Manhattan Psychiatric Center

Completed

Cognitive Skills Training Using Computer for Patients With Severe Mental Illness

Schizophrenia | Schizoaffective Disorder

United States
University of Rochester
National Institute of Mental Health (NIMH); New York University; Weill Medical...

Recruiting

Remediation of Visual Perceptual Impairments in People With Schizophrenia (VRiS)

Schizophrenia | Schizoaffective Disorder

United States
Yale University

Completed

Cannabidiol Treatment in Patients With Early Psychosis (CBD)

Schizophrenia | Schizoaffective Disorder

United States
Columbia University
National Institute of Mental Health (NIMH)

Active, not recruiting

Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH); Columbia University

Completed

Cognitive Remediation for Coordinated Specialty Care

Schizophrenia | Schizoaffective Disorder

United States
Juul Labs, Inc.

Completed

Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, Cigarettes

New Zealand
University of Illinois at Chicago
Weill Medical College of Cornell University; Janssen, LP

Completed

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Manhattan Psychiatric Center
Nathan Kline Institute for Psychiatric Research

Completed

High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder (HDQ)

Schizophrenia | Schizoaffective Disorder

United States
NYU Langone Health
Columbia University; Stanley Medical Research Institute

Withdrawn

Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia

Schizophrenia | Schizoaffective Disorder

United States
Pfizer

Completed

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

Smoking Cessation

United States, Canada
NYU Langone Health

Completed

Biomarkers in First Episode Schizophrenia

Schizophrenia | Schizophreniform Disorder | Schizoaffective Disorder, Depressed Type

United States
US Department of Veterans Affairs
Eli Lilly and Company

Completed

To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Fisher and Paykel Healthcare

Terminated

Physiological Study to Compare Noninvasive Ventilation (NIV) Masks

Sleep-disordered Breathing | Hypercapnia

New Zealand
Centre for Addiction and Mental Health
University of Maryland, Baltimore; National Institutes of Health (NIH); The Feinstein...

Completed

Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders (ModSoCCS)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorders

United States, Canada
Northwell Health
Boston University; University of Pittsburgh; Dartmouth-Hitchcock Medical Center

Completed

Improving Care and Reducing Cost Study (ICRC)

Schizophrenia | Schizoaffective Disorder | Psychosis NOS

United States
University of Maryland, Baltimore
National Institute of Mental Health (NIMH); University of California, Los Angeles and other collaborators

Completed

Adjunctive Treatment for Decreasing Symptoms of Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States, Israel
Zealand University Hospital
University of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...

Completed

The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome (MEDACIS)

Depression | Acute Coronary Syndrome

Denmark

Clinical Trials on Schizoaffective Disorders in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations